본문 바로가기
KERD
논문KCI 등재

최근 5개년 (2013~2017)간 기관지확장증(J47) 환자에게 처방한 급여한약제제 현황 분석 – 건강보험청구자료 중심으로

Herbal medicine prescription analyses of bronchiectasis patients with claim data during 5 years (2013~2017)

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives : Korean national health insurance data is a useful real-world data representing whole medical bills submitted to Health Insurance Review Agency. This study aims to understand recent benefit trend of insurance herbal preparations for treating bronchiectasis(disease code J47) utilizing insurance data. Methods : We reviewed national health insurance claims data from 2013 to 2017 which have main diagnosis or sub diagnosis code of J47 and with the record of prescribing insurance herbal medication. Frequency analysis was performed to analyze the most frequently prescribed prescription. Results & Conclusions : Both the number of claims statement(770 to 1,746cases) and patients(266 to 484) of insurance herbal preparations increased considerably from 2013 to 2017. Top 10 preparations based on the number of claims statement were ‘Samso-eum’, ‘Yeonkyopaedok-san’, ‘Socheongryong-tang’, ‘ Bojungikgitang’, ‘Hyangsapyungwi-san’, ‘Yijin-tang’, ‘Saengmaek-san’, ‘Jaeumganghwa-tang’, ‘Ojeok-san’ and ‘Gunghatang’. Top 10 preparations based on the number of patients were ‘Samso-eum’, ‘Socheongryong-Tang’, ‘Saengmaek-san’, ‘Yeonkyopaedok-san’, ‘Haengso-tang’, ‘Hyangsapyungwi-san’, Yijin-tang’, ‘Jaeumganghwatang’, ‘Bojungikgi-tang’ and ‘Hyeonggaeyeongyo-tang’ in respectiv order. Claims of top 10 frequent preparations occupied more than 60% of total claims. We hope this finding to be utilized as basic data for future research of evidence-based bronchiectasis treatment utilizing Korean traditional medicine.

Abstract

Objectives : Korean national health insurance data is a useful real-world data representing whole medical bills submitted to Health Insurance Review Agency. This study aims to understand recent benefit trend of insurance herbal preparations for treating bronchiectasis(disease code J47) utilizing insurance data. Methods : We reviewed national health insurance claims data from 2013 to 2017 which have main diagnosis or sub diagnosis code of J47 and with the record of prescribing insurance herbal medication. Frequency analysis was performed to analyze the most frequently prescribed prescription. Results & Conclusions : Both the number of claims statement(770 to 1,746cases) and patients(266 to 484) of insurance herbal preparations increased considerably from 2013 to 2017. Top 10 preparations based on the number of claims statement were ‘Samso-eum’, ‘Yeonkyopaedok-san’, ‘Socheongryong-tang’, ‘ Bojungikgitang’, ‘Hyangsapyungwi-san’, ‘Yijin-tang’, ‘Saengmaek-san’, ‘Jaeumganghwa-tang’, ‘Ojeok-san’ and ‘Gunghatang’. Top 10 preparations based on the number of patients were ‘Samso-eum’, ‘Socheongryong-Tang’, ‘Saengmaek-san’, ‘Yeonkyopaedok-san’, ‘Haengso-tang’, ‘Hyangsapyungwi-san’, Yijin-tang’, ‘Jaeumganghwatang’, ‘Bojungikgi-tang’ and ‘Hyeonggaeyeongyo-tang’ in respectiv order. Claims of top 10 frequent preparations occupied more than 60% of total claims. We hope this finding to be utilized as basic data for future research of evidence-based bronchiectasis treatment utilizing Korean traditional medicine.

참고문헌 (34)

  1. Qi Q, "Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial", Respir Res, 20(1), pp.73~ (2019)
  2. Kwak HJ, "High prevalence of bronchiectasis in adults:analysis of CT findings in a health screening program", Tohoku J Exp Med, 222(4), pp.237~242 (2010)
  3. Quint JK, "Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004-2013: a population based cohort study", Eur Respir J, 47(1), pp.186~193 (2016)
  4. Organtzis I, "Bronchiectasis diagnosis and treatment", J Thorac Dis, 7(S1), pp.S97~S98 (2015)
  5. 신영진, "기관지 확장증과 흉추후만을 동반한 복합성 환기장애 치험1례", 한방재활의학과학회지, 16(4), pp.155~161 (2006), 한방재활의학과학회
  6. 전국한의과대학폐계내과학교실, "폐계내과학", pp.449~ (2013), 도서출판 나도
  7. 김재효, "시경반하탕(보험제제)을 통한 기관지확장증 환자의 관리 1례", 대한한방내과학회지, 39(3), pp.443~449 (2018), 대한한방내과학회
  8. 도하윤, "荊芥連翹湯合加味地黃湯으로 호전된 객혈을 호소하는 기관지확장증 환자 1례", 대한한방내과학회지, 39(4), pp.822~830 (2018), 대한한방내과학회
  9. (2019)[URL]
  10. 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
  11. 2017 한약소비실태조사 기초보고서, "보건복지부", ~ (2018)
  12. 고수경, "에피소드 기준을 이용한건강보험 및 의료급여 청구 자료의 재분석: 한방병원 입원의료양상을 중심으로", 한국보건행정학회학술대회논문집, pp.363~ (2005)
  13. 변진석, "한방의료의 건강보험 본인부담 실태분석", 대한예방한의학회지, 10(2), pp.95~120 (2006)
  14. 장용명, "농어촌지역 한방 외래 다빈도 상병의 의료이용 변이분석", 한국산학기술학회논문지, 14(2), pp.713~720 (2013), 한국산학기술학회[DOI]
  15. 류지선, "한의 외래환자분류체계 개선 및 평가", 대한한의학회지, 35(3), pp.93~102 (2014), 대한한의학회
  16. Park S, "Utilization Patterns of Korean Medicine: An Analysis of the National Health Insurance Cohort Database from 2002 to 2013", Journal of alternative and complementary medicine, 22(10), pp.824~831 (2016)
  17. 김봉주, "2014년 건강보험심사평가원 환자표본데이터 분석을 이용한 현훈환자의 의료비용에 관한 연구", 동의신경정신과학회지, 29(3), pp.135~144 (2018), 대한한방신경정신과학회[DOI]
  18. Lee YS, "A retrospective cohort study on the outcomes of ischemic stroke patients with adjuvant Korean Medicine treatment", Scientific reports, 8(1), pp.1656~ (2018)
  19. 이정배, "한국 치매 환자의 건강보험 의ㆍ한의 진료 비용에 관한 연구", 동의신경정신과학회지, 30(1), pp.31~38 (2019), 대한한방신경정신과학회[DOI]
  20. 박주성, "슬관절 전치환술 환자의 의과 및 한의과 의료기관 이용 현황 비교 분석: 건강보험심사평가원 표본 데이터를 이용하여", 한방재활의학과학회지, 29(1), pp.31~39 (2019), 한방재활의학과학회[DOI]
  21. Woo Y, "Effectiveness of Integrative Therapy for Parkinson’s Disease Management", Frontiers in aging neuroscience, 11, pp.40~ (2019)
  22. Huang CW, "Population-based comparison of traditional medicine use in adult patients with allergic rhinitis between South Korea and Taiwan", Journal of the Chinese Medical Association :JCMA, 81(8), pp.708~713 (2018)
  23. 2018년 사망원인통계, "통계청", ~ (2019)
  24. Dudgeon EK, "“The missing ingredient”: the patient perspective of health related quality of life in bronchiectasis:a qualitative study", BMC pulmonary medicine, 18(1), pp.81~ (2018)
  25. Polverino E, "European Respiratory Society guidelines for the management of adult bronchiectasis", Eur Respir J, 50 (2017)
  26. 한약제제 기준처방의 합리적 개선방안 마련을 위한 연구, "원광대학교", 건강보험심사평가원, ~ (2014)
  27. 한약제제 허가사항 관련용어 등 표준화 연구, "글로벌헬스케어 생명과학연구소", 식품의약품안전처, ~ (2006)
  28. 정병주, "기관지확장증과 폐렴이 병발한 고령의 환자를 肺癰으로 辨證한 치험 1例", 대한한방내과학회지, 26(3), pp.626~633 (2005), 대한한방내과학회
  29. 임희용, "肺癰으로 진단된 기관지확장증 환자의 葦莖湯 투여 1례", 대한한방내과학회지, 26(3), pp.652~659 (2005), 대한한방내과학회
  30. Han Dong-Youn, "A Case Study of the Taeumin Bronchiectasis, Wrong Diagnosis as Soyangin", 사상체질의학회지, 16(3), pp.124~128 (2004)
  31. Nakayama M, "A case of chronic lower respiratory tract infection in which the traditional herbal medicine Hochuekkito was effective to prevent exacerbation", Nihon Kokyuki Gakkai zasshi =the journal of the Japanese Respiratory Society, 49(3), pp.232~236 (2011)
  32. Organtzis I, "Bronchiectasis diagnosis and treatment", J Thorac Dis, 7(S1), pp.S97~S98 (2015)[DOI]
  33. Basis of using health insurance data, strategic, and assignment from the computation of health statistic, "J. Kim", ~ (2005)
  34. Hodgson TA, "Cost-of-illness methodology: a guide to current practices and procedures", The Milbank Memorial Fund quarterly Health and society, 60(3), pp.429~462 (1982)

관련 논문AI추천

이 간행물의 다른 논문 (8건)